MENU

Why these could be the best growth shares on the ASX

At this point in time I think the Australian share market is home to a great number of shares with the potential to grow earnings at an explosive rate.

Two, which I believe are worth considering today are listed below. Here’s why I think these growth shares could be great buy and hold investments:

The Appen Ltd (ASX: APX) share price may have gone gangbusters this year and risen a remarkable 33%, but I don’t think it is too late to buy shares in this data solutions and services company. Accelerating demand for Appen’s high quality data for machine learning-based product development recently led to the company upgrading its full-year EBITDA growth guidance to between 40% and 50%. Due to the growing focus on machine learning by tech companies across the globe, I believe Appen is positioned perfectly for strong long-term growth. In light of this, I would put it up there with Nextdc Ltd (ASX: NXT) as one of the best options in the information technology sector.

The CSL Limited (ASX: CSL) share price has risen 35% so far in 2017 thanks largely to a stellar half-year result which saw the biotherapeutics company report a stunning 33% increase in underlying net profit after tax. Its liquid intravenous immunoglobulin Privigen was arguably the star of the show. Sales of Privigen grew 34% over the prior corresponding period. Furthermore, its fledgling Seqirus influenza vaccine business continued to make strong progress and is expected to breakeven in FY 2018. I think Seqirus, the strong demand for its immunoglobulins and plasma collection facilities, and its share repurchase program, should allow CSL to grow its earnings per share at an above average rate for the foreseeable future. In my opinion this makes it the best option in the healthcare sector right now, just ahead of Ramsay Health Care Limited (ASX: RHC).

If you like buy and hold shares with strong growth potential like Appen and CSL, then these quality shares could be perfect for you as well in my opinion.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro owns shares of Nextdc Ltd. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.